All articles A–Z
519,064 articles
Secondary fatty amines
Secondary fatty amines are organic compounds in which one or two long-chain fatty alkyl groups, typically C8 to C22, are bonded to a nitrogen atom that retains one hydrogen.
Secondary female infertility
Secondary female infertility (ICD-11 GA31.1) is infertility in a woman with at least one prior confirmed clinical pregnancy. Causes include tubal damage, ovulation disorders, endometriosis, fibroids, and prior pregnancy or surgical complications; it affects about 11% of US couples.
Secondary flow
Secondary flow is the component of fluid motion perpendicular to a flow's main direction, usually vortical circulation driven by curvature, as in curved pipes and river bends.
Secondary gout
Secondary gout, also called secondary hyperuricemia-related gout, is gout arising during another disease or from drugs, via purine overproduction, nucleic acid turnover, or reduced renal urate clearance; ICD-11 codes FA25.1 include lead- and drug-induced forms.
Secondary growth
Secondary growth: lateral thickening of stems and roots by the vascular cambium and cork cambium, producing wood and periderm in gymnosperms and dicots; rare in monocots, which use a distinct monocot cambium in only about 22 genera.
Secondary haemophagocytic lymphohistiocytosis
Secondary haemophagocytic lymphohistiocytosis (sHLH, secondary HLH): a life-threatening hyperinflammatory syndrome triggered by infection, malignancy, autoimmune disease, or drugs, diagnosed with HLH-2004 criteria or HScore and treated with trigger-directed immunosuppression.
Secondary headache
Secondary headache (ICD-11 8A84) is headache attributed to another causative disorder, spanning ICHD-3 categories 5-12 (trauma, vascular, infection, substances, and others). Distinguished from primary headache by red flags such as thunderclap onset, papilledema, and fever.
Secondary hyperaldosteronism
Secondary hyperaldosteronism (secondary aldosteronism): excess adrenal aldosterone driven by extra-adrenal RAAS activation from reduced renal blood flow, with high renin and aldosterone; causes include renal artery stenosis, heart failure, cirrhosis, nephrotic syndrome; treated by correcting the cause.
Secondary hypercholesterolaemia
Secondary hypercholesterolaemia (acquired hypercholesterolemia, ICD-11 5C80.01) is elevated LDL cholesterol caused entirely by another condition or drug, chiefly hypothyroidism, nephrotic syndrome, cholestasis, pregnancy, ketogenic or high-saturated-fat diets, and agents like thiazides, cyclosporine, and corticosteroids.
Secondary hypereosinophilic syndrome
Secondary hypereosinophilic syndrome (HES-R, reactive HES, ORPHA:314962) is a rare HES variant with polyclonal, cytokine-driven eosinophilia from infections, allergy, drugs, autoimmunity, or non-myeloid malignancy, persisting six months with organ damage.
Secondary hyperparathyroidism
Secondary hyperparathyroidism: excessive but non-autonomous parathyroid hormone production, chiefly from chronic kidney disease and vitamin D deficiency, driven by hypocalcemia, hyperphosphatemia, low calcitriol, and FGF23, and treated with phosphate binders, vitamin D analogs, calcimimetics, or parathyroidectomy.
Secondary hypertension
Secondary hypertension: high blood pressure from an identifiable cause (primary aldosteronism, sleep apnea, renal artery stenosis, renal disease, Cushing, pheochromocytoma). About 5–10% of hypertension overall, up to 30% in young adults; screened with aldosterone-to-renin ratio, metanephrines, imaging.
Secondary hyperthyroidism
Secondary (central) hyperthyroidism: raised free T4/T3 with non-suppressed TSH, caused by TSH-secreting pituitary adenoma (TSHoma) or resistance to thyroid hormone beta; distinguished from assay interference, treated by surgery and somatostatin analogs.
Secondary Immunization
Secondary immunization, or booster dosing, gives vaccine doses after a completed primary series to restore waning immunity or convert first-dose non-responders; CDC and WHO schedule boosters for tetanus, diphtheria, Hib, MMR, and COVID-19.
Secondary intestinal lymphangiectasia
Secondary intestinal lymphangiectasia (ORPHA:90363, ICD-10 I89.0) is acquired intestinal lymphangiectasia causing protein-losing enteropathy from another disorder such as Crohn's disease, congestive heart failure, or the Fontan operation; treatment targets the underlying disease.
Secondary intracranial hypotension
Secondary intracranial hypotension (ICD-11 8D61.1) is low CSF pressure, usually below 60 mm H2O, caused by an identified dural injury such as lumbar puncture, spinal or cranial surgery, shunt placement, or trauma, causing orthostatic headache.
Secondary ion mass spectrometry
Secondary ion mass spectrometry (SIMS) is an analytical technique that determines surface composition by bombarding a sample with primary ions and measuring ejected secondary ions.
Secondary lactase deficiency
Secondary lactase deficiency, or secondary lactose intolerance: loss of intestinal lactase from small bowel injury by infection (rotavirus, Giardia), celiac disease, Crohn's disease, surgery, chemotherapy, or radiation; usually reversible when the underlying cause is treated.
Secondary lichenification
Secondary lichenification (ICD-11 EA83.1): thickened, leathery skin with increased markings caused by repeated rubbing and scratching of skin already affected by a primary pruritic dermatosis such as atopic eczema, psoriasis, or lichen sclerosus.
Secondary lymphedema
Secondary lymphedema is swelling from acquired lymphatic drainage failure, accounting for roughly 85% of lymphedema worldwide, most often after cancer surgery, radiation, or filarial infection.
Secondary lymphoedema
Secondary lymphoedema, or acquired lymphedema, is limb or body swelling from lymphatic damage by cancer treatment, filariasis, trauma, or obesity; managed with decongestive therapy, compression, and microsurgery.
Secondary market
A secondary market, also called a secondary financial market, is where investors buy and sell existing securities after issuance; proceeds go to the selling investor, giving securities liquidity.
Secondary Metabolism
Secondary metabolism produces specialized metabolites, small molecules distinct from primary metabolites, built from acetyl-CoA, amino acids, shikimate, or mevalonate; they defend and signal ecologically and yield antibiotics and other drugs.
Secondary metabolite
Secondary metabolites (specialized metabolites, natural products) are small molecules under 1500 Da from nonessential conditional pathways, including alkaloids, terpenoids, polyketides, and phenylpropanoids; they drive defense, signaling, and most natural-product-derived drugs.
Secondary migration
Secondary migration is the movement of petroleum after expulsion from its source rock through permeable carrier beds toward a trap, driven by buoyancy and limited by capillary pressure.
Secondary mood syndrome
Secondary mood syndrome (ICD-11 6E62; organic affective disorder) is prominent mood symptoms caused directly by a medical condition, coded with depressive, manic, mixed, or unspecified subtypes alongside the causing condition.
Secondary myocardial involvement of systemic disease
Secondary myocardial involvement of systemic disease is heart muscle dysfunction caused by an identifiable systemic condition, including endocrine, nutritional, electrolyte, iron-overload, and storage disorders rather than primary heart disease.
Secondary neutral mass spectrometry
Secondary neutral mass spectrometry (SNMS) is a surface-analysis mass spectrometry technique that post-ionizes neutral atoms sputtered from a sample, avoiding SIMS matrix effects for quantitative depth profiling of thin films.
Secondary oocyte
A secondary oocyte, the cell released at ovulation in humans, forms when a primary oocyte completes the first meiotic division and splits off the first polar body.
Secondary open-angle glaucoma
Secondary open-angle glaucoma: optic neuropathy with an open drainage angle caused by identifiable conditions such as pseudoexfoliation, pigment dispersion, neovascularization, trauma, inflammation, drugs, or lens-induced mechanisms, treated by lowering IOP plus addressing the cause.